In Comparison to Pathological Q Waves, Selvester Score is a Superior Diagnostic Indicator of Increased Long-Term Mortality Risk in ST Elevation Myocardial Infarction Patients Treated with Primary Coronary Intervention.
Q wave
ST elevation myocardial infarction
Selvester score
primary percutaneous coronary intervention
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
28 Apr 2021
28 Apr 2021
Historique:
received:
21
03
2021
revised:
14
04
2021
accepted:
26
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
The development of pathological Q waves has long been correlated with worsened outcome in patients with ST elevation myocardial infarction (STEMI). In this study, we investigated long-term mortality of STEMI patients treated by primary percutaneous coronary intervention (PPCI) and compared predictive values of Q waves and of Selvester score for infarct volume estimation. Data of 283 consecutive STEMI patients (103 females) treated by PPCI were analysed. The presence of pathological Q wave was evaluated in pre-discharge electrocardiograms (ECGs) recorded ≥72 h after the chest pain onset (72 h Q). The Selvester score was evaluated in acute ECGs (acute Selvester score) and in the pre-discharge ECGs (72 h Selvester score). The results were related to total mortality and to clinical and laboratory variables. A 72 h Q presence and 72 h Selvester score ≥6 was observed in 184 (65.02%) and 143 (50.53%) patients, respectively. During a follow-up of 5.69 ± 0.66 years, 36 (12.7%) patients died. Multivariably, 72 h Selvester score ≥6 was a strong independent predictor of death, while a predictive value of the 72 h Q wave was absent. In high-risk subpopulations defined by clinical and laboratory variables, the differences in total mortality were highly significant (
Identifiants
pubmed: 33925108
pii: diagnostics11050799
doi: 10.3390/diagnostics11050799
pmc: PMC8146038
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministry of Health, Czech Republic
ID : FNBr, 65269705
Organisme : British Heart Foundation
ID : New Horizons Grant NH/16/2/32499
Pays : United Kingdom
Organisme : Masaryk University
ID : MUNI/A/1437/2020
Références
Am Heart J. 1979 Aug;98(2):176-84
pubmed: 453020
Circulation. 2002 Mar 5;105(9):1082-7
pubmed: 11877359
Circulation. 2013 Jan 29;127(4):e362-425
pubmed: 23247304
Am J Cardiol. 1982 May;49(7):1604-14
pubmed: 7081049
Eur Heart J. 2012 Oct;33(20):2569-619
pubmed: 22922416
Int J Cardiol. 2019 Aug 15;289:12-18
pubmed: 30665801
J Electrocardiol. 2010 Jul-Aug;43(4):318-25
pubmed: 20381066
Am Heart J. 2002 Aug;144(2):243-50
pubmed: 12177641
J Electrocardiol. 2009 Jan-Feb;42(1):85-96
pubmed: 18790501
Eur Heart J. 2003 Jan;24(1):94-104
pubmed: 12559941
J Cardiovasc Magn Reson. 2008 Apr 09;10:17
pubmed: 18400089
ESC Heart Fail. 2021 Feb;8(1):222-237
pubmed: 33319509
J Am Coll Cardiol. 2002 Feb 6;39(3):556-8
pubmed: 11823101
Am Heart J. 2012 Apr;163(4):563-71
pubmed: 22520521
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Lancet. 2003 Jan 4;361(9351):13-20
pubmed: 12517460
QJM. 2009 Jun;102(6):401-6
pubmed: 19359253
Am Heart J. 2000 Mar;139(3):461-75
pubmed: 10689261
Am J Cardiol. 2010 Sep 1;106(5):630-4
pubmed: 20723636
JACC Cardiovasc Imaging. 2013 Mar;6(3):324-31
pubmed: 23433932
Am J Cardiol. 1998 Apr 1;81(7):809-15
pubmed: 9555767
Glob Heart. 2018 Dec;13(4):305-338
pubmed: 30154043
Eur Heart J. 2007 Oct;28(20):2525-38
pubmed: 17951287
PLoS One. 2017 Mar 9;12(3):e0173699
pubmed: 28278275
BMC Med Ethics. 2019 Oct 14;20(1):70
pubmed: 31610781
Am J Cardiol. 2020 Nov 1;134:8-13
pubmed: 32933755
Circ Cardiovasc Imaging. 2009 May;2(3):183-90
pubmed: 19808591